Our study is the first attempting to analyse the impact of a monoclonal anti‐IL‐4Rα antibody on basophil activation and allergen‐specific T cell proliferation in vitro, in patients with AD and comorbid ARC. The gene discussed is IL4R; the disease is Alzheimer disease.